Particulars |
|
|
|
Company Name
| Astrazeneca Pharma India Ltd
| Year End
| 202503
|
Full Year |
Equity (₹ Cr.) |
5.00 |
B.V. (₹) |
308.10 |
Sales(₹ Cr.) |
1,716.29 |
NP (₹ Cr.) |
175.05 |
NP Var (%) |
17.00 |
Div% |
0.00 |
CPS(₹) |
86.00 |
EPS (₹) |
70.00 |
Traded Value(₹ Lakhs) |
558.05 |
52 Week High |
10,300.00 |
52 Week Low |
6,160.00 |
Price BSE |
10,179.00 |
Price NSE |
10,195.00 |
Market Capital (₹ Cr.) |
25,446.38 |
P/C Ratio |
118.30 |
P/E Ratio |
145.40 |
Price Vs.BV |
33.04 |
|
Latest Quarter |
Year End |
202503 |
Sales (₹ Cr.) |
480.48 |
NP(₹ Cr.) |
62.27 |
NP Var % |
58.00 |
Trailing Twelve Months |
Year End |
202503 |
Sales |
1,484.51 |
OPM |
13.09 |
NP |
128.73 |
NP Var (%) |
17.44 |
EPS |
70.02 |
PE |
145.37 |
|
|